Submitted:
18 April 2026
Posted:
20 April 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Materials and Instruments
2.2. Preparation of Solvent Extracts
2.3. Determination of Total Flavonoid Content
2.4. Quantification of Linarin
2.5. DPPH· Radical Scavenging Assay
2.6. ABTS+· Radical Scavenging Assay
2.7. Ferric Reducing Power Assay
2.8. Hyaluronidase Inhibitory Activity
2.9. 1H NMR Analysis
2.10. UPLC–QTOF–MS Profiling and Tentative Compound Identification
2.11. Data Processing and Correlation Analysis
3. Results
3.1. Total Flavonoid Content of Extracts Prepared with Solvents of Different Polarity
3.2. Linarin Content of Extracts Prepared with Solvents of Different Polarity
3.3. Antioxidant Activity of the Solvent Extracts
3.3.1. DPPH· Radical Scavenging Activity
3.3.2. ABTS+· Radical Scavenging Activity
3.3.3. Ferric Reducing Power
3.4. Hyaluronidase Inhibitory Activity of the Solvent Extracts
3.5. Correlation Among Antioxidant Performance Indices
3.6. Association of Total Flavonoids and Linarin with Antioxidant Performance
3.7. Chemical Profiling of the Most Active Extracts
3.7.1. 1H NMR Spectroscopic Analysis
3.7.2. UPLC–QTOF–MS Analysis and Tentative Compound Identification
4. Discussion
5. Conclusion
Supplementary Materials
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Wang M, Wang S, Tang HP, et al. Buddleja officinalis Maxim.: A review of its botany, ethnopharmacology, phytochemistry, pharmacology, and therapeutic potential for ophthalmic diseases. J Ethnopharmacol. 2024, 318(Pt B): 116993. [CrossRef]
- Asmat U, Abad K, Ismail K. Diabetes mellitus and oxidative stress—A concise review. Saudi Pharm J. 2016, 24(5): 547–553. [CrossRef]
- Chaudhuri J, Bains Y, Guha S, et al. The role of advanced glycation end products in aging and metabolic diseases: Bridging association and causality. Cell Metab. 2018, 28(3):337–352. [CrossRef]
- Fiorentino TV, Prioletta A, Zuo P, Folli F. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr Pharm Des. 2013, 19(32): 5695–5703. [CrossRef]
- Vlassara H, Striker GE. AGE restriction in diabetes mellitus: A paradigm shift. Nat Rev Endocrinol. 2011, 7(9): 526–539. [CrossRef]
- Xie G, Li R, Han Y, Zhu Y, Wu G, Qin M. Optimization of the extraction conditions for Buddleja officinalis Maxim. using response surface methodology and exploration of the optimum harvest time. Molecules. 2017, 22(11): 1877. [CrossRef]
- Huang F B, Liang N, Hussain N, et al. Anti-inflammatory and antioxidant activities of chemical constituents from the flower buds of Buddleja officinalis. Nat Prod Res. 2022, 36(12): 3031–3042. [CrossRef]
- Peng QH, Yao XL, Wu QL, et al. Effects of eye drops of Buddleja officinalis Maxim. extract on lacrimal gland cell apoptosis in castrated rats with dry eye. J Chin Integr Med. 2010, 8(3): 244–249. [CrossRef]
- Peng J, Ouyang Y, Li WJ, et al. Effect of Buddleja officinalis eye drops on inflammatory factors of lacrimal gland cells of castrated male rabbits with dry eye. Int Eye Sci. 2018, 18(8): 1359–1364. [CrossRef]
- Lee YJ, Moon MK, Hwang SM, et al. Anti-inflammatory effect of Buddleja officinalis on vascular inflammation in human umbilical vein endothelial cells. Am J Chin Med. 2010, 38(3): 585–598. [CrossRef]
- Rutkowska M, Kolodziejczyk-Czepas J, Olszewska MA. The effects of Sorbus aucuparia L. fruit extracts on oxidative/nitrative modifications of human fibrinogen, impact on enzymatic properties of thrombin, and hyaluronidase activity in vitro. Antioxidants (Basel). 2021, 10(12): 2009. [CrossRef]
- Bralley EE, Hargrove JL, Greenspan P, Hartle DK. Inhibition of hyaluronidase activity by Vitis rotundifolia berry seeds and skins. Pharm Biol. 2007, 45(8):667–673. [CrossRef]
- Yan XY, Li L. Optimization of ultrasonic-assisted extraction for total flavonoids from Ginkgo biloba leaves and its scavenging capacity on hydroxyl free radicals. Sci Technol Food Ind. 2020, 41(9): 200–204, 224. [CrossRef]
- Wasilewicz A, Areesanan A, Kirchweger B, et al. Combining the strengths of MS and NMR in biochemometrics: A case study on Buddleja officinalis. J Nat Prod. 2025, 88(5):1099–1110. [CrossRef]
- Areesanan A, Wasilewicz A, Kirchweger B, et al. Pharmacological in vitro profiling of Buddleja officinalis flower extracts in the context of dry eye disease. Biomed Pharmacother. 2024, 181:117685. [CrossRef]







| Components | DPPH· index | ABTS⁺· index | Ferric reducing power index |
|---|---|---|---|
| DPPH· index | 1 | – | – |
| ABTS+· index | 0.985, p = 0.002 | 1 | – |
| Ferric reducing power index | 0.809, p = 0.097 | 0.891, p = 0.043 | 1 |
| Component | ABTS+· index | DPPH· index | Ferric reducing power index |
|---|---|---|---|
| Total flavonoids | 0.736 | 0.682 | 0.857 |
| Linarin | 0.832 | 0.812 | 0.830 |
| No. | Compound | Molecular Formula | Rt (min) |
Observed m/z (Adduct) |
Ion Mode | Compound Class | Identification Level | Possible Relevance |
|---|---|---|---|---|---|---|---|---|
| 1 | Echinacoside | C35H46O20 | 4.54 | 785.2525 [M−H]− | ESI− | Phenylethanoid glycoside | Tentative | Phenolic constituent potentially relevant to antioxidant activity |
| 2 | Acteoside (Verbascoside) | C29H36O15 | 5.95 | 623.1973 [M−H]− | ESI− | Phenylethanoid glycoside | Supported by reference standard | Phenylethanoid glycoside associated with antioxidant potential |
| 3 | Forsythoside B | C34H44O19 | 5.26 | 755.2401 [M−H]− | ESI− | Phenylethanoid glycoside | Tentative | Medium-polarity phenolic glycoside relevant to extract-level antioxidant effects |
| 4 | Cistanoside A | C36H48O20 | 5.19 | 799.2636 [M−H]− | ESI− | Phenylethanoid glycoside | Tentative | Phenylethanoid glycoside contributing to the phenolic-rich profile |
| 5 | Linarin | C28H32O14 | 8.08 | 593.1865 [M+H]+ | ESI+ | Flavonoid glycoside | Supported by reference standard | Major quantified marker associated with antioxidant performance |
| 6 | Luteolin-7-O-glucuronide | C21H18O12 | 4.84 | 461.0720 [M−H]− | ESI− | Flavonoid glycoside | Tentative | Flavonoid glycoside consistent with radical-scavenging activity |
| 7 | Baicalin | C21H18O11 | 5.81 | 445.0778 [M−H]− | ESI− | Flavonoid glycoside | Tentative | Flavonoid glycoside contributing to the antioxidant-active fraction |
| 8 | Scutellarin | C21H18O12 | 3.96 | 621.1107 [M−H]− | ESI− | Flavonoid glycoside | Tentative | Representative polar flavonoid glycoside |
| 9 | Isoquercitrin | C21H20O12 | 4.39 | 463.0876 [M−H]− | ESI− | Flavonoid glycoside | Tentative | Phenolic glycoside with potential antioxidant relevance |
| 10 | Chlorogenic acid | C16H18O9 | 2.30 | 353.0871 [M−H]− | ESI− | Phenolic acid | Tentative | Representative phenolic acid supporting the phenolic-rich composition |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).